Find Mobocertinib Succinate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2389149-74-8, Mobocertinib (succinate), Tak-788 succinate, Ap32788 succinate, Ap-32788 succinate, 53qia92zee
Molecular Formula
C36H45N7O8
Molecular Weight
703.8  g/mol
InChI Key
YXYAEUMTJQGKHS-UHFFFAOYSA-N
FDA UNII
53QIA92ZEE

Mobocertinib Succinate
MOBOCERTINIB SUCCINATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for non-small cell lung carcinoma. This drug has a black box warning from the FDA.
1 2D Structure

Mobocertinib Succinate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butanedioic acid;propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate
2.1.2 InChI
InChI=1S/C32H39N7O4.C4H6O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26;5-3(6)1-2-4(7)8/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36);1-2H2,(H,5,6)(H,7,8)
2.1.3 InChI Key
YXYAEUMTJQGKHS-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
53QIA92ZEE
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2389149-74-8

2. Mobocertinib (succinate)

3. Tak-788 Succinate

4. Ap32788 Succinate

5. Ap-32788 Succinate

6. 53qia92zee

7. Unii-53qia92zee

8. Exkivity

9. Propan-2-yl 2-(5-(acryloylamino)-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyanilino)-4-(1-methyl-1h-indol-3-yl)pyrimidine-5-carboxylate Succinate

10. Mobocertinib Succinate (jan)

11. Mobocertinib Succinate [jan]

12. Butanedioic Acid;propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate

13. 788succinic Acid

14. Exkivity (tn)

15. Tak788 Succinate

16. Tak 788 Succinate

17. Ap 32788 Succinate

18. Mobocertinib (succinate)?

19. Chembl4802239

20. Schembl25406916

21. Wlz3772

22. Glxc-25145

23. Bcp33315

24. Ex-a3982

25. At30194

26. Hy-135815a

27. Mobocertinib Succinate [who-dd]

28. Da-65572

29. Ms-31177

30. Tak-788 Succinate; Ap32788 Succinate

31. Mobocertinib Succinate [orange Book]

32. Cs-0114257

33. D11969

34. Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1h-indol-3-yl)pyrimidine-5-carboxylate Succinic Acid

35. Propan-2-yl 2-(4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxy-5-(prop-2-enamido)anilino)-4-(1-methyl-1h-indol-3-yl)pyrimidine-5-carboxylate Monosuccinate

36. Propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate Succinate

37. Tak-788 Succinate; Ap32788 Succinate;tak 788 Succinate; Ap 32788 Succinate;tak788 Succinate; Ap-32788 Succinate

2.4 Create Date
2020-04-30
3 Chemical and Physical Properties
Molecular Weight 703.8 g/mol
Molecular Formula C36H45N7O8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count13
Rotatable Bond Count16
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area188
Heavy Atom Count51
Formal Charge0
Complexity1030
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty